Value-based insurance design for pharmacare
Description
In this interview, Dr. Steve Morgan and Dr. Kai Yeung discuss a possible framework for pharmacare. They argue and explain that setting copayments based on drugs’ clinical and economic value can promote patient choice and encourage cost-conscious